Palo Alto startup Medable scores $91M as it helps to speed Covid vaccine trials
November 19, 2020 at 09:58 AM EST
The company says its technology has helped accelerate development of vaccines and therapeutics for Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|